|
2008
|
Invention
|
Screening, therapy and diagnosis. A TREM-1 ligand is identified. This allows various derivatives ... |
|
|
Invention
|
Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof.
Novel act... |
|
|
Invention
|
Synthesis of 1α-fluoro-25-hydroxy-16-23e-diene-26,27-bishomo-20-epi-cholecalciferol. The in... |
|
2007
|
Invention
|
Method for treating benign prostatic hyperplasia.
The use of 1-alpha-fluoro-25-hydroxy-16,23E-di... |
|
|
Invention
|
Novel method of treatment of male sub-fertility.
There is provided a method of treatment of male... |
|
|
Invention
|
Novel method of treatment of male sub-fertility. There is provided a method of treatment of male ... |
|
|
Invention
|
Novel method.
There is provided a method of prevention of adhesions, eg surgical adhesions, whic... |
|
|
Invention
|
Use of vitamin d compounds for the prevention of adhesions. There is provided a method of prevent... |
|
2006
|
Invention
|
1,25-dihydroxy, 20-cyclopropyl,26-27-deuteroalkyl vitamin d3 compounds and methods of use thereof... |
|
|
Invention
|
1,25 - dihydroxy, 20-cyclopropyl, 26-27- deuteroalkyl vitamin d3 compounds and methods of use the... |
|
|
Invention
|
Synthesis of 1a-fluoro-25-hydroxy-16-23e-diene-26,27-bishomo-20-epi-cholecalciferol.
The inventi... |
|
|
Invention
|
Synthesis of 1&agr;-fluoro-25-hydroxy-16-23e-diene-26,27-bishomo-20-epi-cholecalciferol. The inve... |
|
|
Invention
|
Use of vitamin d3 compounds for the treatment of uveitis. The invention provides for the use of v... |
|
|
Invention
|
Novel method. The invention provides for the use of Vitamin D compounds such as 1-alpha-fluoro-25... |
|
|
Invention
|
Methods of treating osteoporosis and secondary hyperparathyroidism using 20-methyl, gemini vitami... |
|
|
Invention
|
20-alkyl, gemini vitamin d3 compounds and methods of use thereof.
The invention provides 20-alky... |
|
|
Invention
|
Use of vitamin d compounds to treat endometriosis.
The use of vitamin D compounds in the treatme... |
|
|
Invention
|
20-alkyl, gemini vitamin d3 compounds and methods of use thereof. The invention provides 20-alkyl... |
|
|
Invention
|
Use of vitamin d compounds to treat endometriosis. The use of vitamin D compounds in the treatmen... |
|
|
Invention
|
Method for the prevention and treatment of uveitis.
The invention provides 1,3-di-acylated vitam... |
|
2005
|
Invention
|
Therapeutic peptides and method.
A polypeptide comprising one or more sequences derived from CDR... |
|
|
Invention
|
Combined use of vitamin d derivatives and anti-proliferative agents for treating bladder cancer. ... |
|
|
Invention
|
Gemini vitamin d3 compounds and methods of use thereof.
The invention provides Gemini vitamin D3... |
|
|
Invention
|
Use of vitamin d compounds for the prevention or treatment of chronic prostatitis. The use of a v... |
|
|
Invention
|
20-cyclopropyl, 26,27-alkyl/haloalkyl vitamin d3 compounds and methods of use thereof.
The inven... |
|
|
Invention
|
20-cycloalkyl,26,27-alkyl/haloalkyl vitamin d3 compounds and methods of use thereof. The inventio... |
|
|
Invention
|
Therapeutic peptides comprising sequences derived from cdr2 or cdr3 of trem-1 and uses thereof to... |
|
|
Invention
|
Treatment of interstitial cystitis with vitamin d compounds. There is provided according to the i... |
|
|
Invention
|
Method of diagnosing infectious disease by measuring the level of soluble trem-1 in a sample. The... |
|
2004
|
Invention
|
1,3-diacylated, 26,27-alkyl/haloakyl vitamin d3 compounds and methods of use thereof.
The invent... |
|
|
Invention
|
Methods for treating bladder dysfunction.
There is provided according to the invention the use o... |
|
|
Invention
|
1,3-diaclyated,26,27-alkyl/haloalkyl vitamin d3 compounds and methods of use thereof. The inventi... |
|
|
Invention
|
Methods for treating bladder dysfunction. There is provided according to the invention the use of... |
|
|
Invention
|
Use of vitamin d3 analogue for the treatment of benign prostatic hyperplasia. The use of 1-alpha-... |
|
|
Invention
|
Method for treating benign prostatic hyperplasia. The use of 1-alpha-fluoro-25-hydroxy-16,23E-die... |
|
|
Invention
|
Use of vitamin d3 analogue for the treatment of autoimmune diabetes. The present invention is con... |
|
|
Invention
|
1,3 aclyated 24-keto-vitamin d3 compounds and methods of use thereof.
The invention provides 1,3... |
|
|
Invention
|
1,3 aclyated 24-keto-vitamin d3 compounds and methods of use thereof. The invention provides 1,3 ... |
|
|
Invention
|
Gemini vitamin d3 compounds and methods of use thereof. The invention provides Gemini vitamin D3 ... |
|
|
Invention
|
Diagnostic and prognostic compounds and method. The present invention relates to a method of diag... |
|
2003
|
Invention
|
A novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof. Novel ac... |
|
2002
|
Invention
|
Use of a vitamin d3 analogue for the treatment of autoimmune diabetes. The present invention is c... |
|
|
Invention
|
Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof. Novel acti... |
|
2001
|
Invention
|
Novel method.
The invention provides for the use of Vitamin D compounds such as 1-alpha-fluoro-2... |
|
1998
|
Invention
|
16-ene-26,27-bishomo cholecalciferols. The invention relates to a compound of the formula ##STR1#... |
|
1997
|
Invention
|
22-epimeric-1,25-dihydroxy-16,22,23-triene-cholecalciferol. Compounds of formula I are useful as ... |
|
1994
|
Invention
|
Vitamin d3 analogs for the treatment of psoriasis and sebaceous gland diseases. Compounds of the ... |
